IP Library Patent Application 16948230
Patent Application
App. No. 16/948,230

ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/948,230
Abstract

Disclosed is an antibody which binds to risperidone, which can be used to detect risperidone in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of risperidone, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.

Claims (45)

1 - 25 . (canceled)

26 . An isolated antibody or a binding fragment thereof, which binds to risperidone and which is generating in response to a conjugate of a compound of Formula I and an immunogenic carrier,

wherein:

R 1 is H, or OH;

R 2 is O(CH 2 ) r NH 2 ,

or O(CH 2 ) r NHC(O)(CH 2 ) m CO 2 H;

wherein:

r is 1, 2, 3, 4, or 5;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

27 . The antibody or binding fragment thereof of claim 26 , wherein the antibody binding fragment is selected from the group of fragments consisting of Fv, F(ab′), F(ab′)2, scFv, minibody and diabody fragments.

28 . The antibody or binding fragment thereof of claim 26 , wherein the antibody is a monoclonal antibody.

29 . The antibody or binding fragment thereof of claim 26 , wherein the immunogenic carrier is a protein.

30 . The antibody or binding fragment thereof of claim 29 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

31 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5; and

m is 1, 2, 3, 4, or 5.

32 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5; and

m is 1, 2, 3, 4, or 5.

33 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

34 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5;

m is 1, 2, 3, 4, or 5; and

n is 1, 2, 3, 4, or 5.

35 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5; and

m is 1, 2, 3, 4, or 5.

36 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

r is 1, 2, 3, 4, or 5; and

m is 1, 2, 3, 4, or 5.

37 . The antibody or binding fragment thereof of claim 26 , wherein the compound is selected from the group consisting of:

38 . The antibody or binding fragment thereof of claim 26 , wherein the compound is

39 . The antibody or binding fragment thereof of claim 26 , wherein the conjugate is

R 1 is H, or OH; and

m is 1, 2, 3, 4, or 5.

40 . The antibody or binding fragment thereof of claim 39 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

41 . The antibody or binding fragment thereof of claim 39 , wherein the conjugate is

42 . The antibody or binding fragment thereof of claim 41 , wherein the conjugate is

43 . An assay kit comprising the antibody or binding fragment thereof of claim 26 .

44 . An assay device comprising the antibody or binding fragment thereof of claim 26 .

45 . The assay device of claim 44 , wherein the device is a lateral flow assay device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: JANSSEN PHARMACEUTICA NV
To: SALADAX BIOMEDICAL INC.
Reel/Frame 059137/0641 →